CCL3 and infection: In this approach, immunomodulators—primarily proinflammatory cytokines, such as CCL3, or bacterial products, such as N-Formylmethionine-leucyl-phenylalanine (fMLF)—are used to mobilize and activate innate immune responses at the possible site(s) of infection [8,188,189].